Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation study
0
Zitationen
29
Autoren
2025
Jahr
Abstract
Surgical resection improves survival in glioblastoma, yet predicting the extent of resection (EOR) remains highly challenging. We developed and externally validated an explainable AI model to generate personalized EOR estimates in 811 glioblastoma patients undergoing microsurgical resection. EOR was categorized into gross-total (GTR), near-total (NTR), and subtotal resections (STR). An interpretable framework provided model explanations and sensitivity analyses to assess the model's strengths and limitations. To demonstrate clinical impact, we compared the performance of the human expert (gold standard) with our AI model and a combined human-AI approach. External validation confirmed generalizability (AUC 0.78, CI 0.73-0.82). Class-specific AUCs were 0.75 (0.67-0.82) for GTR, 0.59 (0.50-0.69) for NTR, and 0.69 (0.53-0.85) for STR. Key predictors included KPS and NANO scores, age, tumor volume, and unfavorable anatomical locations. A combined human-AI collaboration outperformed human experts, with higher overall accuracies (0.53 to 0.94), F1 scores (0.30 to 0.92), and Cohen's κ (0.41 to 0.84). Enhancing predictive performance through the clinician-AI collaboration, our explainable model supports preoperative planning and highlights the value of integrating machine intelligence into surgical decision-making.
Ähnliche Arbeiten
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · 21.269 Zit.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 · 15.739 Zit.
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 · 13.889 Zit.
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 · 12.081 Zit.
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 · 11.120 Zit.
Autoren
- Julius M. Kernbach
- Ulrik Schroeder
- Karlijn Hakvoort
- Jonas Ort
- Hussam Aldin Hamou
- Danilo Bzdok
- Yasin Temel
- Pieter Kubben
- Charlotte S. Weyland
- Martin Wiesmann
- Victor E. Staartjes
- Kevin Akeret
- Moira Vieli
- Carlo Serra
- Luca Regli
- Stefan Grau
- Lasse Dührsen
- Franz Ricklefs
- Oliver Schnell
- D. Ryan Ormond
- Alexander Grote
- Matthias Simon
- Hagen Meredig
- Marianne Schell
- Martin Bendszus
- Georg Neuloh
- Hans Clusmann
- Dieter-Henrik Heiland
- Daniel Delev
Institutionen
- Heidelberg University(DE)
- Universitätsklinikum Aachen(DE)
- RWTH Aachen University(DE)
- Montreal Neurological Institute and Hospital(CA)
- Mila - Quebec Artificial Intelligence Institute(CA)
- Maastricht University Medical Centre(NL)
- Maastricht University(NL)
- University of Zurich(CH)
- University Hospital of Zurich(CH)
- Philipps University of Marburg(DE)
- University of Cologne(DE)
- Fulda University of Applied Sciences(DE)
- Universität Hamburg(DE)
- University Medical Center Hamburg-Eppendorf(DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)
- University of Colorado Anschutz Medical Campus(US)
- Evangelisches Krankenhaus Bielefeld(DE)
- Klinikum Bremerhaven-Reinkenheide(DE)